印度对涉华间苯二酚启动反倾销调查！应本土唯一生产商Atul Limited申请
世界农化网中文网报道：2026年6月18日，印度商工部贸易救济总局（DGTR）发布第6/21/2026-DGTR号公告，应印度国内唯一生产企业Atul Limited提交的申请，正式对原产于或进口自中国和日本的间苯二酚（Resorcinol）启动反倾销调查。
Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell Engineering
MaxCyte and VectorBuilder believe that a new standard for non-viral gene delivery can be enabled, i.e., one that enhances cell quality, improves manufacturing efficiency, and provides developers with a more streamlined path from research through commercialization. [Mohammed Haneefa Nizamudeen/Getty Images]
WA Mouse Outbreaks Reaching Plague Levels
June 2026, AU: Grain growers are urged to maintain mouse monitoring throughout winter and, if required, consider additio…
美国农业部调高2026年作物成本预估，2027年压力有增无减
世界农化网中文网报道：美国农业部近日发布最新《Commodity Costs and Returns》报告，首次系统评估了全球能源与化肥市场波动对农场层面的传导效应。报告显示，2026年种植季所有主要作物的生产成本均较此前预期上调，且2027年将进一步攀升至历史新高。
投资2.5亿元，内蒙古灵圣拟建年产1.2万吨嘧菌酯等的关键中间体4,6-二羟基嘧啶
世界农化网中文网报道：近日，内蒙古灵圣作物科技有限公司年产12000吨4,6-二羟基嘧啶项目环评受理公示。
Cytomos’ AuraCyt Digital Predictive Cell Analytics Platform Showcased at BIO Conference
Cytomos reports that it is showcasing its flagship cell analytic intelligence platform AuraCyt®, together with its novel Celledonia® benchtop technology, which is designed to boost predictive cell analytics. Current challenges in the bioprocessing space include slow, label-dependent analytical methods that are inefficient to scale-up and provide limited predictive insight, according to Cytomos.
Digital Tool Provides a Quick Check on Herbicide Mix Efficacy
June 2026, Colorado: Two Weed Science Society of America (WSSA) member scientists have helped create a digital tool to e…
El Niño is Coming. Here Is Where The Risks To Agriculture Are Highest
June 2026, Rome: A new El Niño phase is likely to begin within weeks, putting agriculture on alert around the world. New…
Americans’ Demand for Non-UPF Proteins Boosts Pulmuone’s Tofu Sales by 17%
With high-protein, high-fibre and minimally processed foods firmly in focus in the US, one company is witnessing a surge in sales of a product that combines all three.
Jellatech Partners with South Korea’s Hugel to Bring Cell-Cultured Human Collagen to Market
Jellatech is inching closer to bringing its recombinant human collagen to market, having partnered with Seoul-based medical aesthetics company Hugel to advance its cell culture platform’s development and commercialisation.